Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the embolotherapy market grown over the years?

The embolotherapy sector has seen robust expansion in its size in previous years. It is projected to rise from $4.44 billion in 2024 to $4.86 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. The significant growth during the historical period is due to the escalating demand for embolotherapy treatments, a surge in cancer occurrences, an uptick in peripheral vascular disease cases, increased healthcare spending, and intensified research investment.

What Is the forecasted market size and growth rate for the embolotherapy market?

Predictions for the embolotherapy market size suggest substantial growth in the coming years. The market is set to expand to the value of $6.83 billion by 2029, with a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this upward trajectory during the forecast period include an increase in disposable income, a rise in the occurrence of chronic diseases, heightened usage in reproductive health, an increasing amount of cheoembolization procedures, and a growing number of liver cancer cases. Key trends that can be expected within the forecast period consist of advanced technologies, digital and analog devices, insertable cardiac monitors, embolotherapy techniques, and strategic partnerships.

Get your embolotherapy market report here!

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

What are the major factors driving growth in the embolotherapy market?

The embolotherapy market’s growth is anticipated to be fueled by the increasing inclination towards minimally invasive procedures. These are cosmetic treatments that mostly eliminate the need for surgery, involve brief recovery periods and carry fewer risks. The escalating popularity of these procedures is spurred by factors such as quicker recovery times, less pain, minimal scarring, decreased risk of complications, and technological advancements. Embolotherapy strengthens minimally invasive treatments by specifically hindering blood flow to target vessels, reducing hemorrhaging, treating tumors, and dealing with vascular anomalies with enhanced accuracy and reduced complications. For example, the American Society of Plastic Surgeons, a non-profit organization in the US, reported in September 2023 that cosmetic minimally invasive procedures escalated by 7% in 2023, reaching 25,442,640 from 23,672,269 in 2022. Hence, the rising popularity of minimally invasive treatments is propelling the expansion of the embolotherapy market.

What key areas define the segmentation of the global embolotherapy Market?

The embolotherapy market covered in this report is segmented –

1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices

2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders

3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)

4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users

Subsegments:

1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils

2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles

3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons

4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems

5) By Support Devices: Guidewires, Catheters, Sheath Introducers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp

What are the top market players propelling the growth of the embolotherapy industry?

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc

What emerging trends are influencing the growth of the embolotherapy market?

Leading participants in the embolotherapy market are emphasizing the development of innovative products such as dissolvable embolic apparatus to improve patient results and diversify treatment solutions. Dissolvable embolic devices make use of bioresorbable substances in embolization procedures to curtail blood supply to desired tissues like tumors or aneurysms, and they eventually decompose within the body. In January 2025, for instance, Instylla Inc., a medical equipment producer based in the United States, gained U.S. Food and Drug Administration (FDA) 510(k) approval for its Tembo embolic mechanism. This is a bioresorbable agent for embolization composed of unevenly shaped, dry-gelatin particles, ranging from 85 to 255 µm. The Tembo system is purposed to embolize hypervascular tumours and to block blood vessels in the peripheral vasculature. Instylla reports that Tembo provides benefits including straightforward preparation, excellent visibility, and capacity to fill treated vessels densely, offering possible enhancements to existing permanent embolic interventions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21181

What regions are dominating the embolotherapy market growth?

North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Migraine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-global-market-report

Migraine Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Infection Control Global Market Report 2025

https://thebusinessresearchcompany.com/report/infection-control-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: